John Bernard Payne, President and CEO at Zivo Bioscience, Inc. (ZIVO), bought 6,343 shares at $0.16 ($1000) on 2024-10-16, disclosed to the SEC on 2024-10-16.
Open-market purchase of $1,000 ZIVO by President and CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| ZIVO | BUY | 2022-12-20 | $143 | — | Filing → |
| ZIVO | BUY | 2022-01-28 | $23K | — | Filing → |